Suvretta Capital Management, LLC Immatics N.V. Transaction History
Suvretta Capital Management, LLC
- $2.91 Billion
- Q2 2025
A detailed history of Suvretta Capital Management, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 12,030,129 shares of IMTX stock, worth $69.9 Million. This represents 2.23% of its overall portfolio holdings.
Number of Shares
12,030,129
Previous 9,135,029
31.69%
Holding current value
$69.9 Million
Previous $41.2 Million
57.1%
% of portfolio
2.23%
Previous 1.8%
Shares
4 transactions
Others Institutions Holding IMTX
# of Institutions
74Shares Held
93.6MCall Options Held
158KPut Options Held
0-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.3MShares$106 Million0.06% of portfolio
-
Baker Bros. Advisors LP New York, NY10.2MShares$59.1 Million0.55% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$54.5 Million2.22% of portfolio
-
Rtw Investments, LP New York, NY6.97MShares$40.5 Million0.58% of portfolio
-
Vestal Point Capital, LP New York, NY6.25MShares$36.3 Million1.77% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $443M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...